Correlation of Quantitated Intravascular Volume with Blood Pressure in Patients with Systemic Hypertension.


Journal

Journal of cardiovascular translational research
ISSN: 1937-5395
Titre abrégé: J Cardiovasc Transl Res
Pays: United States
ID NLM: 101468585

Informations de publication

Date de publication:
08 2020
Historique:
received: 12 07 2019
accepted: 23 08 2019
pubmed: 30 8 2019
medline: 2 12 2020
entrez: 30 8 2019
Statut: ppublish

Résumé

Volume management is an essential component of anti-hypertensive therapy. Different volume phenotypes have been proposed. We sought to study the total blood volume (TBV), plasma volume (PV), and red blood cell volume (RBV) in hypertensive patients. We included patients followed in an outpatient cardiology clinic from 1998 to 2003. Blood volume (BV) parameters were measured using radioisotope iodine-131-labeled albumin dilution technique. Values were expressed as percentage (%) deviation from ideal volumes. A total of 95 patients were included. The intravascular volume distribution as percent deviation from normal volume ranged from - 23 to + 28% for TBV, - 22 to + 36% for PV and - 29 to + 37% for RBV. There was no significant correlation between systolic BP and any of the BV parameters (TBV and SBP, r = - 0.03; PV and SBP, r = - 0.12; RBV and SBP, r = - 0.08). Patients with hypertension have a wide variation in BV parameters. BV does not correlate with SBP.

Identifiants

pubmed: 31463701
doi: 10.1007/s12265-019-09910-4
pii: 10.1007/s12265-019-09910-4
pmc: PMC8034589
mid: NIHMS1687322
doi:

Substances chimiques

Serum Albumin, Radio-Iodinated 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

528-530

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007101
Pays : United States

Références

Heart. 2003 Sep;89(9):1104-9
pubmed: 12923045
Am J Med Sci. 2007 Jul;334(1):41-6
pubmed: 17630591
Circulation. 1977 Oct;56(4 Pt 1):605-12
pubmed: 902387
Hypertension. 1979 Mar-Apr;1(2):136-41
pubmed: 399939
Fed Proc. 1982 Jun;41(8):2415-23
pubmed: 7084486
Am J Med. 1977 Feb;62(2):209-18
pubmed: 835600

Auteurs

Marat Fudim (M)

Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC, USA. marat.fudim@dm.duke.edu.
Duke Clinical Research Institute, Durham, NC, USA. marat.fudim@dm.duke.edu.

Vanessa L Blumer (VL)

Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC, USA.

Renato D Lopes (RD)

Duke Clinical Research Institute, Durham, NC, USA.

Patrick Rossignol (P)

CIC-Inserm 1433, Inserm U1116, Nancy University hospital, and FCRIN INI-CRCT, University of Lorraine, Nancy, France.

Michael Feldschuh (M)

Daxor, New York, NY, USA.

Wayne L Miller (WL)

Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Paul A Sobotka (PA)

Department of Medicine, Ohio State University, Columbus, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH